In early 2022, the launch team at a top-ten biotech company was in the planning stage for a new oncology product launch. The team was considering packaging options and needed to understand the perspectives of one of their most important customers: pharmacists. Being the ultimate arbiter in many fulfillment decisions, minor optimizations in packaging could lead to a major impact during the commercial launch.
The launch team had less than two weeks to make key launch strategy recommendations, with particular focus on packaging strategy. The team needed robust, defensible insights from target pharmacists to substantiate their recommendations within ten days.
Learn how ZoomRx helped the team make data-backed decisions from a robust, nimble research study and what the learnings revealed about packaging choices.